Načítá se...
Deciphering the ovarian cancer ascites fluid peptidome
BACKGROUND: Conventional proteomic approaches have thus far been unable to identify novel serum biomarkers for ovarian cancer that are more sensitive and specific than the current clinically used marker, CA-125. Because endogenous peptides are smaller and may enter the circulation more easily than p...
Uloženo v:
| Vydáno v: | Clin Proteomics |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4230032/ https://ncbi.nlm.nih.gov/pubmed/24694173 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1559-0275-11-13 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|